You are here: Industry Insights > sepsis

News List

Ulinastatin in Japan, China, and India David Orchard-Webb
October 09, 2024
Ulinastatin, a naturally occurring protease modulator generated from human urine, has been used for decades to treat inflammatory disorders like sepsis, acute pancreatitis, and organ failure.
Even at Same Hospital, Black Patients Face More Complications Than Whites drugs
July 23, 2021
Black Americans admitted for inpatient hospital care are far more likely than white patients to experience safety-related health complications -- even when both are treated in the same facility, a new report warns.
Claritas to expand Covid-19 trial to include sepsis treatment pharmaceutical-technology
April 12, 2021
Claritas Pharmaceuticals is set to expand its development programme for R-107 to include the treatment of Covid-19 related sepsis, which is the leading cause of death in infected patients.
New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis prnasia
March 17, 2021
VolitionRx Limited, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has been working with Swiss-based Santersus AG, a ...
Israeli Ministry of Health Authorizes Trial Evaluating Allocetra in Sepsis Patients americanpharmaceuticalreview
November 12, 2020
Enlivex Therapeutics reported the Israeli Ministry of Health authorized the initiation of a proposed Company-sponsored Phase IIb clinical trial evaluating Allocetra™, in sepsis patients.
New study assessing antibiotics for COVID-19 sepsis pharmatimes
November 04, 2020
Researchers from an NIHR-funded study are looking at how to improve the use of antibiotics for patients with COVID-19 who are at risk of developing sepsis and thus organ failure and death.
Scientists discover 59 repurposing drug candidates for COVID-19 pharmatimes
May 14, 2020
As of this morning – Thursday May 14 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 229,705 with 33,186 deaths.
India’s CSIR proposes testing of sepsis drug as Covid-19 vaccine pharmaceutical-technology
May 08, 2020
The Council of Scientific and Industrial Research (CSIR) in India has proposed the testing of sepsis treatment drug as a vaccine for Covid-19.
Enlivex Initiates Phase II Trial of Allocetra in COVID-19 contractpharma
May 08, 2020
Will assess Allocetra in combination with therapy in patients with lung dysfunction.
Enlivex Announces Positive Final Safety and Efficacy Data from Allocetra Study americanpharmaceuticalreview
March 20, 2020
Enlivex Therapeutics announced positive final safety and efficacy data from the Company’s completed Phase Ib clinical trial in patients with severe sepsis.

Previous page 1 2 3 Next page